Advertisement Rosetta Genomics reports allowance of two patents - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Rosetta Genomics reports allowance of two patents

Rosetta Genomics has said that the US Patent and Trademark Office has issued a notice of allowance for two of the company's patent applications on human and viral microRNAs.

The first allowed patent application is related to two clustered human hairpins and their related microRNAs. The second allowed patent application is related to microRNA US5-1, a viral microRNA found in human cytomegalovirus (HCMV), a member of the herpes virus family.

Amir Avniel, president and CEO of Rosetta Genomics, said: “Combining our proprietary microRNAs with microRNAs discovered in collaboration with Johns Hopkins University exclusively licensed to Rosetta Genomics, we believe we have exclusive access to the majority of known human and viral microRNA genes. In addition, we have in-licensed microRNAs from leading research institutes in this field.”